Zacks.com on MSN22d
Inogen Stock Gains Following Solid Preliminary Q4 Revenues
In October 2024, Inogen commenced the U.S. market release of the Rove 4 Portable Oxygen Concentrator (POC ... improved profitability and disciplined cost management during 2024. The achievements in ...
gasworld11d
Yuwell to invest $27m in Inogen to boost oxygen potential
Leading oxygen concentrator manufacturers Yuwell Medical and Inogen have announced an investment tie up to advance their medical device and respiratory businesses. Yuwell, through its whole-owned ...
Zacks.com on MSN10d
Inogen Stock May Gain on Deal With Yuwell to Expand Global Reach
INGN and Yuwell collaborate to expand and enhance Inogen's innovation pipeline through R&D collaboration and accelerate the entry of Inogen's brand into the Chinese market.
Yahoo Finance23d
Inogen Stock Gains Following Solid Preliminary Q4 Revenues
In October 2024, Inogen commenced the U.S. market release of the Rove 4 Portable Oxygen Concentrator (POC ... improved profitability and disciplined cost management during 2024.
Nasdaq10d
Inogen Stock May Gain on Deal With Yuwell to Expand Global Reach
The collaboration with Yuwell is beneficial for INGN stock price as it strengthens ... The flagship Inogen One G4 provides a single-solution portable oxygen concentrator (POC), while the Inogen ...
Big News Network.com11d
Arab Health 2025Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health
Inogen, a leading U.S. manufacturer of oxygen concentrators, brings extensive experience in portable oxygen concentrator technology. Yuwell, through its whole-owned subsidiary Yuwell (Hong Kong) ...
Inogen’s Strategic Moves and Market Developments Lead to Hold Rating Amid Modest Near-Term Financial Impact
Needham analyst Michael Matson has maintained their neutral stance on INGN stock, giving a Hold rating on January 14.Invest with Confidence: ...